• Users Online: 118
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 

 Table of Contents  
Year : 2019  |  Volume : 4  |  Issue : 2  |  Page : 64

CTDD call for papers

Date of Web Publication9-Jul-2019

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2542-3975.260961

Rights and Permissions

How to cite this article:
. CTDD call for papers. Clin Trials Degener Dis 2019;4:64

How to cite this URL:
. CTDD call for papers. Clin Trials Degener Dis [serial online] 2019 [cited 2022 Nov 29];4:64. Available from: https://www.clinicaltdd.com/text.asp?2019/4/2/64/260961

Dear Professors,

Clinical Trials in Degenerative Diseases (CTDD) has offered to publish a collection of publishing articles on clinical trials, research, pathogenesis, diagnosis, treatments, epidemiology and education for all aspects of degenerative diseases. We believe this is an excellent opportunity to present the latest works being done in this very hot and fast moving topic.

We cordially invite you to contribute or recommend appropriate works (such as research articles, reviews/mini-reviews, protocols, retrospective studies, case series/reports, and editorial material) to the coming two issues in 2019. We understand that a journal’s Impact Factor is important for a variety of reasons to many in its community of authors. We encourage all readers to prioritize a journal based on their own evaluation of the work it publishes, regardless of whether it has an Impact Factor or the actual value of that metric. Authors of accepted papers will be granted complete waiver for all fees and published within 2019. Our editorial staff will assist with smooth editorial and peer review process. Instructions for Authors can be accessed at www.clinicaltdd.com/contributors.asp.

Reasons to Publish with Us

  • Complete charge waiver
  • High international visibility – freely accessible to view and search
  • Simple and flexible submission process – guided by experienced in-house editors
  • User-friendly website – search, filter and download trial records

Abstract and Indexing Information

The journal is registered with the following abstracting partners: Google Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing’s Electronic Databases, Exlibris – Primo Central, Baidu Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet.

The journal is indexed with, or included in, the following: DOAJ, and in the process of applying for listing by PubMed Central, E-SCI.

Scope of the Journal

CTDD is an open access, peer-reviewed, online journal with quarterly print on demand compilation of issues published. The journal is committed to publishing articles on general trial methodology as well as protocols, commentaries and traditional results papers – regardless of outcomes or significance of findings. The topics include but are not limited to the following: Degenerative heart diseases, Cancer, Metabolic degeneration, Neurodegenerative disorders, Orthopedic degenerative diseases and Degenerative eye diseases.

Journals Featured on Our Publishing House

  • Neural Regeneration Research (2018 impact factor: 2.472, indexed by SCI-E, PubMed)
  • Medical Gas Research (indexed by E-SCI, MEDLINE)
  • Asia Pacific Journal of Clinical Trials: Nervous System Diseases
  • Clinical Trials in Orthopedic Disorders
  • Glioma
  • Journal of Bio-X Research
  • International Journal of Heart Rhythm

Your contribution and assistance will be highly appreciated. Thank you for considering our invitation.

With best regards,

Editorial Office of CTDD


Similar in PUBMED
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded153    
    Comments [Add]    

Recommend this journal